Detection of Plasma T790M Mutation After the First Generation EGFR-TKI Resistance of Non-Small Cell Lung Cancer in the Real World

被引：0
|
作者：
Li, H. [1 ]
Lv, D. [1 ]
Xu, H. [1 ]
Ye, M. [2 ]
Wu, X. [1 ]
Kong, F. [3 ]
Yang, H. [3 ]
机构：
[1] Wenzhou Med Univ, Affiliated Taizhou Hosp Enze, Dept Pulm Med, Taizhou, Peoples R China
[2] Wenzhou Med Univ, Affiliated Taizhou Hosp, Dept Thorac Surg, Taizhou, Peoples R China
[3] Wenzhou Med Univ, Affiliated Taizhou Hosp, Enze Med Hlth Acad, Radiat Oncol,Radiat Oncol Inst, Taizhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Plasma EGFR Thr790Met (T790M); Acquired resistance;
D O I：
10.1016/j.jtho.2019.08.1250
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.16-24
引用
收藏
页码：S595 / S596
页数：2
相关论文
共 50 条
  • [1] Detection of plasma T790M mutation after the first generation EGFR-TKI resistance of non-small cell lung cancer in the real world
    Li, Haiyan
    Wang, Jinwei
    Zhang, Guojing
    Li, Yuping
    Lin, Ling
    Yang, Haihua
    Zhou, Jingjing
    Zhang, Lingna
    Lv, Dongqing
    [J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (03) : 550 - 557
  • [2] The Feasibility of Interventional Pulmonology Methods for Detecting the T790M Mutation after the First or Second-Generation EGFR-TKI Resistance of Non-Small Cell Lung Cancer
    Cheng, Wen-Chien
    Shen, Yi-Cheng
    Chen, Chieh-Lung
    Liao, Wei-Chih
    Chen, Hung-Jen
    Hsia, Te-Chun
    Chen, Chia-Hung
    Tu, Chih-Yen
    [J]. DIAGNOSTICS, 2023, 13 (01)
  • [3] Non-Small Cell Lung Cancer with Resistance to EGFR-TKI Therapy: CT Characteristics of T790M Mutation-positive Cancer
    Koo, Hyun Jung
    Kim, Mi Young
    Park, Sojung
    Lee, Han Na
    Kim, Hwa Jung
    Lee, Jae Cheol
    Kim, Sang-We
    Lee, Dae Ho
    Choi, Chang-Min
    [J]. RADIOLOGY, 2018, 289 (01) : 227 - 237
  • [4] Role of T790M Mutation in EGFR-TKI Rechallenge for Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer
    Zhang, Qiu-Yi
    Ke, E-E
    Deng, Wei
    Niu, Fei-Yu
    Zhao, Ning
    Su, Jian
    Chen, Zhi-Hong
    Yang, Jin-Ji
    Xu, Chong-Rui
    Yan, Hong-Hong
    Wu, Yi-Long
    Zhou, Qing
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S271 - S271
  • [5] Safety and activity of alflutinib in patients with advanced EGFR T790M mutation non-small cell lung cancer who progressed after EGFR-TKI therapy
    Shi, Y-K.
    Zhang, S.
    Hu, X.
    Feng, J.
    Ma, Z.
    Zhou, J.
    Yang, N.
    Wu, L.
    Liao, W.
    Han, X.
    Wang, Z.
    Zhang, X.
    Qin, S.
    Ying, K.
    Feng, J.
    Fang, J.
    Liu, L.
    Jiang, Y.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 629 - 629
  • [6] Osimertinib in previously EGFR-TKI treated non-small cell lung cancer (NSCLC) patients without T790M mutation: Real-world evidence.
    Luo, Yung-Hung
    Liu, Han
    Wampfler, Jason A.
    Tazelaar, Henry D.
    Li, Yalun
    Peikert, Tobias
    Liu, Dan
    Leventakos, Konstantinos
    Chen, Yuh-Min
    Yang, Yanan
    Chiou, Shih-Hwa
    Yang, Ping
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Osimertinib for advanced non-small cell lung cancer harboring EGFR mutation exon 20 T790M, acquired resistant mutation for first- or second-generation EGFR-TKI
    Okuma, Yusuke
    Hosomi, Yukio
    [J]. JOURNAL OF THORACIC DISEASE, 2017, 9 (03) : 470 - 473
  • [8] Influence of plasma T790M mutation on clinical decision after 1st generation EGFR-TKI resistance in a Real-world study
    Zhang, S.
    Zhu, L.
    Xia, B.
    Chen, X.
    Ma, S.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [9] REBIOPSY OF NON-SMALL CELL LUNG CANCER PATIENTS WITH ACQUIRED RESISTANCE TO EGFR-TKI: COMPARISON BETWEEN T790M MUTATION-POSITIVE AND -NEGATIVE POPULATIONS
    Hata, A.
    [J]. RESPIROLOGY, 2012, 17 : 82 - 82
  • [10] Rebiopsy of non-small cell lung cancer patients with acquired resistance to EGFR-TKI: Comparison between T790M mutation-positive and -negative populations
    Hata, Akito
    Katakami, Nobuyuki
    Yoshioka, Hiroshige
    Takeshita, Jumpei
    Tanaka, Kosuke
    Nanjo, Shigeki
    Kaji, Reiko
    Fujita, Shiro
    Imai, Yukihiro
    Monden, Kazuya
    Matsumoto, Takeshi
    Nagata, Kazuma
    Otsuka, Kyoko
    Tachikawa, Ryo
    Tomii, Keisuke
    Kunimasa, Kei
    Iwasaku, Masahiro
    Nishiyama, Akihiro
    Ishida, Tadashi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345